ARTICLE SUMMARY:
Device companies haven’t yet brought forward the right interventions to help the obesity market reach its enormous potential. With a “procedureless” medical implant that’s supported by a connected health device and app for ongoing patient support, young company Allurion appears to have the formula for success.
The problem—some say epidemic—of obesity has been tough for medical device companies to get their arms around.
